134
Views
6
CrossRef citations to date
0
Altmetric
Original Articles: Gynaecology

Prevalence of Neisseria gonorrhoeae and Trichomonas vaginalis in Portuguese women of childbearing age

, , , , & ORCID Icon

References

  • Borges-Costa J, Matos C, Pereira F. 2012. Sexually transmitted infections in pregnant adolescents: prevalence and association with maternal and foetal morbidity. Journal of the European Academy of Dermatology and Venereology 26:972–975.
  • Brotman RM. 2011. Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective. Journal of Clinical Investigation 121:4610–4617.
  • Brotman RM, Melendez JH, Smith TD, Galai N, Zenilman JM. 2010. Effect of menses on clearance of Y-chromosome in vaginal fluid: implications for a biomarker of recent sexual activity. Sexually Transmitted Diseases 37:1–4.
  • Carne CA, Gibbs J, Delaney A, Sonnex C, Verlander NQ, Smielewska A, et al. 2013. Prevalence, clinical features and quantification of genital non-viral infections. International Journal of STD & AIDS 24:273–277.
  • De Jong AS, Rahamat-Langendoen JC, Van alphen P, Hilt N, Van Herk C, Pont S, et al. 2016. Large two-centre study into the prevalence of Mycoplasma genitalium and Trichomonas vaginalis in the Netherlands. International Journal of STD & AIDS 27:856–860.
  • Depuydt CE, Leuridan E, Van Damme P, Bogers J, Vereecken AJ, Donders GG. 2010. Epidemiology of Trichomonas vaginalis and human papillomavirus infection detected by real-time PCR in flanders. Gynecologic and Obstetric Investigation 70:273–280.
  • DGS. 2014. Doenças de Declaração Obrigatória Portugal 2011–2014 (Volume I). Direcção Geral da Saúde-Portugal.
  • Faber MT, Nielsen A, Nygard M, Sparen P, Tryggvadottir L, Hansen BT, et al. 2011. Genital chlamydia, genital herpes, Trichomonas vaginalis and gonorrhea prevalence, and risk factors among nearly 70,000 randomly selected women in 4 Nordic countries. Sexually Transmitted Diseases 38:727–734.
  • Field N, Clifton S, Alexander S, Ison CA, Khanom R, Saunders P, et al. 2018. Trichomonas vaginalis infection is uncommon in the British general population: implications for clinical testing and public health screening. Sexually Transmitted Infections 94:226–229.
  • Garcia A, Exposto F, Prieto E, Lopes M, Duarte A, Correia Da Silva R. 2004. Association of Trichomonas vaginalis with sociodemographic factors and other STDs among female inmates in Lisbon. International Journal of STD & AIDS 15:615–618.
  • Garland SM, Tabrizi SN. 2004. Diagnosis of sexually transmitted infections (STI) using self-collected non-invasive specimens. Sexual Health 1:121–126.
  • Geelen TH, Hoebe CJ, Dirks A, Dukers-Muijrers NH, Van Bergen JE, Wolffs PF. 2013. Low positivity rate after systematic screening for Trichomonas vaginalis in three patient cohorts from general practitioners, STI clinic and a national population-based chlamydia screening study. Sexually Transmitted Infections 89:532–534.
  • Harper DM, Noll WW, Belloni DR, Cole BF. 2002. Randomized clinical trial of PCR-determined human papillomavirus detection methods: self-sampling versus clinician-directed–biologic concordance and women’s preferences. American Journal of Obstetrics and Gynecology 186:365–373.
  • Ho B, Feng W, Wong B, Egglestone S. 1992. Polymerase chain reaction for the detection of Neisseria gonorrhoeae in clinical samples. Journal of Clinical Pathology 45:439–442.
  • Hoebe CJ, Rademaker CW, Brouwers EE, Ter Waarbeek HL, Van Bergen JE. 2006. Acceptability of self-taken vaginal swabs and first-catch urine samples for the diagnosis of urogenital Chlamydia trachomatis and Neisseria gonorrhoeae with an amplified DNA assay in young women attending a public health sexually transmitted disease clinic. Sexually Transmitted Diseases 33:491–495.
  • Kengne P, Veas F, Vidal N, Rey J-L, Cuny G. 1994. Trichomonas vaginalis: repeated DNA target for highly sensitive and specific polymerase chain reaction diagnosis. Cellular and Molecular Biology 40:819–831.
  • Workowski KA, Bolan GA; Centers for Disease Control and Prevention.. 2015. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommendations and Reports 64:1–137.
  • Leli C, Castronari R, Levorato L, Luciano E, Pistoni E, Perito S, et al. 2016. Molecular sensitivity threshold of wet mount and an immunochromatographic assay evaluated by quantitative real-time PCR for diagnosis of Trichomonas vaginalis infection in a low-risk population of childbearing women. Le Infezioni in Medicina 24:112–116.
  • Longatto-Filho A, Roteli-Martins C, Hammes L, Etlinger D, Pereira SM, Erzen M, et al. 2008. Self-sampling for human papillomavirus (HPV) testing as cervical cancer screening option. Experience from the LAMS study. European Journal of Gynaecological Oncology 29:327–332.
  • Luo ZZ, Li W, Wu QH, Zhang L, Tian LS, Liu LL, et al. 2018. Population-based study of chlamydial and gonococcal infections among women in Shenzhen, China: implications for programme planning. PLOS One 13:e0196516.
  • Mgone CS, Lupiwa T, Yeka W. 2002. High prevalence of Neisseria gonorrhoeae and multiple sexually transmitted diseases among rural women in the Eastern Highlands Province of Papua New Guinea, detected by polymerase chain reaction. Sexually Transmitted Diseases 29:775–779.
  • Miller WC, Swygard H, Hobbs MM, Ford CA, Handcock MS, Morris M, et al. 2005. The prevalence of trichomoniasis in young adults in the United States. Sexually Transmitted Diseases 32:593–598.
  • Newman L, Rowley J, Vander Hoorn S, Wijesooriya Ns, Unemo M, Low N, et al. 2015. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLOS One 10:e0143304.
  • Pellrud H, Golparian D, Nilsson CS, Falk M, Fredlund H, Unemo M. 2015. Trichomonas vaginalis infections are rare among young patients attending an STI clinic in Sweden. Acta Dermato Venereologica 95:343–344.
  • Pereyre S, Laurier Nadalié C, Bébéar C, Arfeuille C, Beby-Defaux A, Berçot B, et al. 2017. Mycoplasma genitalium and Trichomonas vaginalis in France: a point prevalence study in people screened for sexually transmitted diseases. Clinical Microbiology and Infection 23:122.e1–122.e7.
  • Petignat P, Faltin DL, Bruchim I, Tramer MR, Franco EL, Coutlee F. 2007. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecologic Oncology 105:530–535.
  • Rao GG, Bacon L, Evans J, Dejahang Y, Michalczyk P, Donaldson N. 2008. Prevalence of Neisseria gonorrhoeae infection in young subjects attending community clinics in South London. Sexually Transmitted Infections 84:117–121.
  • Shone J, Winter A, Jones BL, Butt A, Brawley D, Cunningham C, et al. 2016. A Scottish multi-centre service evaluation examining the prevalence and diagnosis of Trichomonas vaginalis in symptomatic women attending sexual health clinics. International Journal of STD & AIDS 27:1066–1070.
  • Silva J, Cerqueira F, Medeiros R. 2015. Y chromosome DNA in cervicovaginal self-collected samples of childbearing age women: implications for epitheliotropic sexually transmitted infections? Life Sciences. 139:62–68.
  • Silva J, Cerqueira F, Medeiros R. 2017. Acceptability of self-sampling in Portuguese women: the good, the bad or the ugly? Sex Health 14:298–300.
  • Silva J, Cerqueira F, Teixeira AL, Bicho MC, Campainha R, Amorim J, Medeiros R. 2018. Genital mycoplasmas and ureaplasmas in cervicovaginal self-collected samples of reproductive-age women: prevalence and risk factors. International Journal of STD & AIDS 29:999–1006.
  • Sutton M, Sternberg M, Koumans EH, Mcquillan G, Berman S, Markowitz L. 2007. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001–2004. Clinical Infectious Diseases 45:1319–1326.
  • Sutton S, Rutherford C. 2005. Sociodemographic and attitudinal correlates of cervical screening uptake in a national sample of women in Britain. Social Science & Medicine 61:2460–2465.
  • Webb R, Richardson J, Esmail A, Pickles A. 2004. Uptake for cervical screening by ethnicity and place-of-birth: a population-based cross-sectional study. Journal of Public Health 26:293–296.
  • WHO 2012. Global incidence and prevalence of selected curable sexually transmitted infections – 2008. Geneva: World Health Organization.
  • WHO 2016. Guidelines for the treatment of Neisseria gonorrhoeae. Geneva: World Health Organization.
  • WHO 2018. Gonorrhoea-incidence rate (per 100,000 population). [Online]. Copenhagen, Denmark: World Health Organization Regional Office for Europe: World Health Organization Regional Office for Europe; [cited 2018 Jul 23]. Available from: http://data.euro.who.int/cisid.
  • Wiesenfeld HC, Lowry DL, Heine RP, Krohn MA, Bittner H, Kellinger K, et al. 2001. Self-collection of vaginal swabs for the detection of Chlamydia, gonorrhea, and trichomoniasis: opportunity to encourage sexually transmitted disease testing among adolescents. Sexually Transmitted Disease 28:321–325.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.